Sit Investment Associates’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Sit Investment Associates's HALO Position: Q1 2024 in Review
Sit Investment Associates sold out of Halozyme (HALO) in Q1 2024, closing a stake of 20,225 shares — an estimated $748K sold.
Sit Investment Associates first reported a position in HALO in Q4 2014 and held it in 21 quarters. The position peaked at $3.06M in Q4 2022. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.
- Sit Investment Associates reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
- Sit Investment Associates sold 20,225 Halozyme shares in Q1 2024, an estimated $748K.
- Sit Investment Associates first reported a position in Halozyme in Q4 2014 and held it in 21 quarters.
- Sit Investment Associates's Halozyme position peaked at $3.06M in Q4 2022.
- 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.
Based on Sit Investment Associates's 13F filing for Q1 2024, filed 14 May 2024.